Detalhe da pesquisa
1.
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only.
Oncologist
; 21(3): 279-80, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26911408
2.
A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers.
Cancer Invest
; 34(5): 213-9, 2016 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27127841
3.
Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment.
Cytotherapy
; 18(5): 653-63, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27059202
4.
Generation of highly cytotoxic natural killer cells for treatment of acute myelogenous leukemia using a feeder-free, particle-based approach.
Biol Blood Marrow Transplant
; 21(4): 632-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25576425
5.
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.
Lancet Gastroenterol Hepatol
; 5(3): 285-294, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953079